Article PDF
Avoid common mistakes on your manuscript.
References
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126: 663–676
Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Südhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature, 2010, 463: 1035–1041
Kong F, Zheng CY, Xu DW. Telomerase as a “stemness” enzyme. Sci China Life Sci, 2014, 57: 564–570
Zhao C. Paracrine signaling in stem cell renewal and in neoplastic tumor growth. Sci China Life Sci, 2014, 57: 571–574
An SM, Ding Q, Zhang J, Xie JY, Li LS. Targeting stem cell signaling pathways for drug discovery: advances in the Notch and Wnt pathways. Sci China Life Sci, 2014, 57: 575–580
Xie XY, Li YH, Pei XT. From stem cells to red blood cells: how far away from the clinical application? Sci China Life Sci, 2014, 57: 581–585
Wang W, Cao W. Treatment of osteoarthritis with mesenchymal stem cells. Sci China Life Sci, 2014, 57: 586–595
Author information
Authors and Affiliations
Corresponding authors
Additional information
This article is published with open access at link.springer.com
Biographical Sketch Chen ZhiGuo, Ph.D., Professor, Cell Therapy Center, Xuanwu Hospital Capital Medical University. He obtained his bachelor’s degree from Department of Biochemistry and Molecular Biology, Nankai University in 1999 and then continued to pursue the Ph.D. degree in Department of Neurotec, Karolinska Institute, Sweden, with the degree thesis focusing on Neuroscience. In 2004, he was recruited to Stanford University as a postdoctoral fellow and worked on stem cell biology, particularly on the regulation and application of neural stem cells. In 2010, Dr. Chen started to work at Cell Therapy Center, Xuanwu Hospital Capital Medical University and continued his research on stem cell biology and regenerative medicine. In the past years, he has made contributions that shed light on the mechanisms underlying the immunological regulation of neural stem cells, and the application of native and reprogrammed neural cells for Parkinson’s disease therapy.
Biographical Sketch Zhang Yu, Ph.D. Senior Director, AP Head of Early-to-Candidate Unit, SARD. He was selected to the Special Program for the Gifted Young at the University of Science and Technology of China, where he got his bachelor’s degree. He obtained his Ph.D. from Northwestern University and continued his research at Stanford University. Prior to joining sanofi aventis in 2008, Alex had been a professor at Capital Medical University in Beijing and director of Cell Therapy Center at Xuanwu Hospital for eight years. Originally trained as a neuroscientist in the field of developmental neurobiology, Dr. Zhang’s current research interest focuses on the understanding of basic biological properties of stem cells and developing nonhuman primate models for stem cell-based therapy of degenerative diseases. His research on using pancreatic progenitor cells in treating diabetes has demonstrated efficacy in monkey models and is pending for clinical trials in human patients.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Chen, Z., Zhang, Y. Introduction to the special topic “Stem cells and regenerative medicine”. Sci. China Life Sci. 57, 561–563 (2014). https://doi.org/10.1007/s11427-014-4671-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-014-4671-9